Phil Campbell - Carmell Therapeutics Founder Officer
| CTCXDelisted Stock | 0.20 0.00 0.00% |
Founder
Phil Campbell is Founder Officer of Carmell Therapeutics
| Phone | 919 313 9633 |
| Web | https://www.carmellcosmetics.com |
Carmell Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.0639) % which means that it has lost $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1565) %, meaning that it created substantial loss on money invested by shareholders. Carmell Therapeutics' management efficiency ratios could be used to measure how well Carmell Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | FOUNDER Age | ||
| Mark Merrill | NETGEAR | 69 | |
| Barbara Baekgaard | Vera Bradley | 86 | |
Management Performance
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0639 |
Carmell Therapeutics Leadership Team
Elected by the shareholders, the Carmell Therapeutics' board of directors comprises two types of representatives: Carmell Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carmell. The board's role is to monitor Carmell Therapeutics' management team and ensure that shareholders' interests are well served. Carmell Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carmell Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James MD, Founder | ||
| Kendra BrackenFerguson, Chief Officer | ||
| Rajiv Shukla, Executive Chairman | ||
| Lee Weiss, Founder | ||
| Phil Campbell, Founder Officer | ||
| Bryan Cassaday, Chief Officer |
Carmell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Carmell Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0639 | |||
| Operating Margin | (69.19) % | |||
| Current Valuation | 5.59 M | |||
| Shares Outstanding | 30.12 M | |||
| Shares Owned By Insiders | 20.30 % | |||
| Shares Owned By Institutions | 8.88 % | |||
| Number Of Shares Shorted | 94.21 K | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 180.96 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Carmell Stock
If you are still planning to invest in Carmell Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Carmell Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |